Organigram Holdings Stock Z Score
OGI Stock  USD 1.76 0.02 1.15% 
OrganiGram  Z Score 
OrganiGram Holdings Company Z Score Analysis
OrganiGram Holdings' ZScore is a simple linear, multifactor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
 
 
 
 

OrganiGram Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for OrganiGram Holdings is extremely important. It helps to project a fair market value of OrganiGram Stock properly, considering its historical fundamentals such as Z Score. Since OrganiGram Holdings' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of OrganiGram Holdings' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of OrganiGram Holdings' interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate a ZScore, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. ZScores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with ZScores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a socalled 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize zscores proved it to be successful as a predictor of corporate bankruptcy.
Competition 
Based on the company's disclosures, OrganiGram Holdings has a Z Score of 0.0. This is 100.0% lower than that of the Pharmaceuticals sector and about the same as Health Care (which currently averages 0.0) industry. The z score for all United States stocks is 100.0% higher than that of the company.
OrganiGram Holdings Institutional Holders
Institutional Holdings refers to the ownership stake in OrganiGram Holdings that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of OrganiGram Holdings' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in highprofile magazines, and presentations at investor conferences help move the stock higher, increasing OrganiGram Holdings' value.Shares  
Two Sigma Advisers, Llc  20240630  101.2 K  
Polar Asset Management Partners  20240630  75 K  
Jane Street Group, Llc  20240630  48.5 K  
Canton Hathaway, Llc  20240630  41 K  
Vontobel Holding Ltd.  20240630  40.6 K  
Clear Harbor Asset Management, Llc  20240630  32.8 K  
Citadel Advisors Llc  20240630  29 K  
State Of Wyoming  20240630  28.9 K  
Morgan Stanley  Brokerage Accounts  20240630  24.7 K  
Tidal Investments Llc.  20240630  1.8 M  
Advisorshares Investments, Llc  20240630  1 M 
OrganiGram Fundamentals
Return On Equity  0.55  
Return On Asset  0.0556  
Profit Margin  (1.54) %  
Operating Margin  (0.12) %  
Current Valuation  132.52 M  
Shares Outstanding  108.57 M  
Shares Owned By Insiders  31.32 %  
Shares Owned By Institutions  8.36 %  
Number Of Shares Shorted  2.7 M  
Price To Earning  (79.96) X  
Price To Book  0.87 X  
Price To Sales  1.28 X  
Revenue  149.21 M  
Gross Profit  35.07 M  
EBITDA  (88.23 M)  
Net Income  (229.48 M)  
Cash And Equivalents  127.36 M  
Cash Per Share  0.41 X  
Total Debt  4.72 M  
Debt To Equity  0.01 %  
Current Ratio  4.17 X  
Book Value Per Share  2.85 X  
Cash Flow From Operations  (35.19 M)  
Short Ratio  3.71 X  
Earnings Per Share  (1.86) X  
Target Price  8.8  
Number Of Employees  914  
Beta  1.13  
Market Capitalization  191.09 M  
Total Asset  298.45 M  
Retained Earnings  (538.53 M)  
Working Capital  166.34 M  
Current Asset  204.52 M  
Current Liabilities  54.43 M  
Net Asset  298.45 M 
About OrganiGram Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OrganiGram Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OrganiGram Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OrganiGram Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
OEF  iShares SP 100  
GLD  SPDR Gold Shares  
OIH  VanEck Oil Services  
IBB  iShares Biotechnology ETF  
IJH  iShares Core SP 
Additional Information and Resources on Investing in OrganiGram Stock
When determining whether OrganiGram Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OrganiGram Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organigram Holdings Stock. Outlined below are crucial reports that will aid in making a wellinformed decision on Organigram Holdings Stock:Check out OrganiGram Holdings Piotroski F Score and OrganiGram Holdings Valuation analysis. For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OrganiGram Holdings. If investors know OrganiGram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.86)  Revenue Per Share 1.835  Quarterly Revenue Growth (0.14)  Return On Assets (0.06)  Return On Equity (0.55) 
The market value of OrganiGram Holdings is measured differently than its book value, which is the value of OrganiGram that is recorded on the company's balance sheet. Investors also form their own opinion of OrganiGram Holdings' value that differs from its market value or its book value, called intrinsic value, which is OrganiGram Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OrganiGram Holdings' market value can be influenced by many factors that don't directly affect OrganiGram Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OrganiGram Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if OrganiGram Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OrganiGram Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.